Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers

Journal of Medical Genetics

Volumn 46, Issue 6, 2009, Pages 423-424

  Manchanda, R ^a   Rosenthal, A ^a   Burnell, M ^a   Fraser, L ^a   Mackay, J ^a   Skates, S ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; EARLY CANCER; HETEROZYGOTE; HUMAN; LETTER; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS;

FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; MASS SCREENING; NEOPLASM STAGING; OVARIAN NEOPLASMS;

EID: 67449168642     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmg.2009.067462     Document Type: Letter

References (3)

1. Evans G, Gaarenstroom K, Stirling D, Shenton A, Maehle L, Dørum A, Steel M, Lalloo F, Apold J, Porteous M, Vasen H, van Asperen C, Pal Moller P. Screening for familial ovarian cancer: poor survival in BRCA 1/2 related cancers. J Med Genet Published Online First 15 April 2008. doi:10.1136/jmg.2008. 058248.
2. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 2000;66:1259-1272 (Pubitemid 30468783)
3. Hirsh-Yechezkel G, Chetrit A, Lubin F, Friedman E, Peretz T, Gershoni R, Rizel S, Struewing JP, Modan B. Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel. Gynecol Oncol 2003;89:494-498 (Pubitemid 36687798)